GeneDx Holdings Corp. - Cogs Excluding Depreciation and Amortization

GeneDx Holdings Corp.'s Fiscal Year is From January To December - All Figures are in USD, Millions.

The item "Cogs-Excluding-Depreciation-and-Amortization" stands at 98.18 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2023.

GeneDx Holdings Corp.'s third quarter result of 25.74 Million USD for the item "Cogs Excluding Depreciation and Amortization" represents an increase of 0.56 percent compared to it's second quarter result.

Also, GeneDx Holdings Corp.'s third quarter result of 25.74 Million USD for the item "Cogs Excluding Depreciation and Amortization" represents an increase of 11.36 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), GeneDx Holdings Corp.'s third quarter result of 98.18 Million USD for the item "Cogs Excluding Depreciation and Amortization" represents an increase of 2.75 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 14.44 percent compared to the value the year prior.
The 1 year change in percent is 14.44.
The 3 year change in percent is -51.23.

The Serie's long term average value is 130.25 Million United States Dollars. It's latest available value, on 09/30/2025, is 24.62 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is +24.55%.
The Serie's change in percent from it's maximum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is -51.43%.